Background. Age-related conditions such as glaucoma, age-related macular degeneration, diabetic retinopathy, and cataract have become the major cause of visual impairment and blindness in high-income countries. The aim of the current study is to investigate the prevalence of these eye diseases in a cohort of self-proclaimed healthy elderly and thus get a rough estimation of the prevalence of undiagnosed age-related eye conditions in the Belgian population. Methods. Individuals aged 55 and older without ophthalmological complaints were asked to fill in a general medical questionnaire and underwent an ophthalmological examination, which included a biomicroscopic examination, intraocular pressure measurement, axial length measurement, and acquisition of fundus pictures and optical coherence tomography scans. Information regarding follow-up was collected in those who received the advice of referral to an ophthalmologist or the advice to have more frequent follow-up visits, based on their study evaluation. Results. The cohort included 102 people and comprised 46% men (median age 70 years, range 57–85 years). Referral for additional examinations was made in 26 participants (25%). The advice to have more regular follow-up ophthalmologist visits was given to nine additional participants (9%). No significant correlations between baseline characteristics and the need for referral could be identified. Follow-up information was available for 25 out of 26 referred volunteers. Out of these, four underwent a therapeutic intervention based on study referral, up until 18 months after study participation. All four interventions took place in the age group 65–74 years. Conclusions. This study shows that, even in an elderly population with self-proclaimed healthy eyes and good general health, a significant proportion of subjects showed ocular findings that need regular follow-up and/or intervention. The frequency of prior ophthalmological examinations does not seem to be relevant to this proportion, meaning that everyone above 55 years old needs a routine ophthalmological evaluation.
1. Introduction
Age-related ocular diseases are the major cause of visual impairment and blindness in high-income countries and carry a major socioeconomic burden. Western Europe roughly counts one million (0.6%) blind and three to ten million (1.7–5.6%) visually impaired persons older than 40 years [1]. Age-related conditions such as cataract, age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy (DRP) have become the mainstay of visual decline in the Western world and account for more than half of cases of blindness in those aged 50 or older and for 35% of cases of visual impairment in the same age group. As a single cause of visual impairment, uncorrected refractive error continues to take the lead in all age groups, worldwide as well as in high-income countries [2].
Projections made by Finger and Scholl estimate that visual impairment will affect 5–25% of an elderly population in a high-income region over a 5- to 15-year period, with age being the most significant risk factor [1]. Visual impairment in the elderly negatively affects quality of life and increases the need for care because of increased fall risk, loss of independence, depression, and increased all-cause mortality [3–8]. A large longitudinal observational study in American adults concluded that regular eye examinations for those aged 65 or older are a protective factor for the development of decline in both vision and functional status [9]. This link between receipt of care and visual and functional outcome reinforces the current professional guidelines by the American Academy of Ophthalmology (AAO), which advocate a complete eye exam with an ophthalmologist every year or two after the age of 65 [10]. When it comes to screening for impaired visual acuity in elderly, however, current evidence appears to be insufficient to assess the balance of benefits and harms, as concluded by the US Preventive Services Task Force. The reason for these findings is the lack of well-designed studies demonstrating conclusive benefits of universal eye screening in the elderly [11].
Furthermore, glaucoma, and to a lesser extent AMD and DRP, are characterized by irreversible damage and vision loss, emphasizing the need for early diagnosis and treatment to delay the development of significant visual impairment. More than half of glaucoma cases remain undiagnosed, even in developed regions [12–15], despite widely available eye care facilities [16–18]. Glaucoma screening remains controversial because of the lack of data, economic evaluations, and accurate screening test algorithms [19–21], and diagnosis is mostly made by routine opportunistic case finding as there is no evidence for a useful screening tool to date. Nevertheless, the debate is ongoing and more evidence could argue for targeted screening or even for mass screening for glaucoma if more effective diagnostic tools become available. On the other end of the spectrum, glaucoma overdiagnosis and overtreatment is a relevant health issue, as pointed out by various authors and reviewed by González-Martín-Moro and Zarallo-Gallardo [12, 17, 22–25].
This study investigates the prevalence of age-related eye diseases in a cohort of self-proclaimed healthy elderly to get a rough estimation of the prevalence of undiagnosed age-related eye conditions in the Belgian population. The results underline the potential benefit of screening for a subset of prevalent sight-threatening age-related eye diseases in an elderly population, preferentially before the onset of impactful visual decline.
2. Materials and Methods
2.1. Study Design
This single-center cross-sectional study took place at University Hospitals UZ Leuven, Department of Ophthalmology, Leuven, Belgium, during April 2017. Elderly individuals free of known ophthalmological diseases were recruited from the members of the Third Age University Leuven, a KU Leuven initiative that offers a continued education program to the over-55-year-olds.
Those who received the advice of referral to an ophthalmologist or the advice to have more frequent follow-up visits, based on their participation in this study, received a questionnaire regarding their follow-up status in November 2018 (18 months after study participation).
Individuals with a known ophthalmological condition, besides refractive error or pseudophakia, and those with subjectively suboptimal visual acuity were excluded.
2.2. Study Population and Research Methods
The cohort included 102 people and comprised 46% men (median age 70 years, range 57–85 years). Inclusion criteria were members of the Third Age University Leuven (thus aged ≥55 years), with self-proclaimed healthy eyes and good general health. Written informed consent was obtained from each volunteer prior to inclusion in the study in compliance with relevant regulation on clinical trials. Individual results were discussed with each participant. In the case of an abnormal result, the participant was referred for further diagnostic work-up or regular follow-up.
2.3. Ophthalmological Examination
Subjects were asked to fill in a questionnaire on their personal and familial general and ocular history. A basic ophthalmological examination of both eyes of each participant was performed, including biomicroscopy, intraocular pressure (IOP) measurement by rebound tonometry using an iCare® TA01i tonometer (Tiolat Oy, Helsinki, Finland), axial length (AXL) measurement by IOL Master 700 (Carl Zeiss Meditec AG, Jena, Germany), dilated fundoscopy, and stereoscopic optic disc photography as well as macula-centered fundus photography using the Visucam PRO NM (Carl Zeiss Meditec AG, Jena, Germany) and optical coherence tomography (OCT) using the glaucoma module of the OCT Spectralis (Heidelberg Engineering, Heidelberg, Germany). The subset of volunteers that received advice to have further exams or more frequent follow-up received a questionnaire concerning their follow-up status where they were asked to answer questions about ophthalmologist visits since participating in this study and ocular interventions. All data were anonymized prior to analysis.
2.4. Statistical Analysis
Statistical analyses were performed using IBM SPSS® 25.0 for Windows (IBM, Armonk, New York, USA). Continuous variables were tested for normality using the Shapiro–Wilk test. Continuous variables are presented as the median, minimum, and maximum because they were not normally distributed . Binary variables are presented as numbers and percentages. Nominal variables are presented as numbers with percentages per category. To statistically compare variables between groups, the Mann–Whitney U test was used for continuous variables and the chi-square test was used for dichotomous and nominal variables. Pairwise correlation was additionally assessed using Spearman’s rank correlation coefficients. The influence of age, gender, education, smoking status, diabetes, arterial hypertension, neurological pathology, autoimmune pathology, intraocular lens status, familial history of glaucoma, familial history of AMD, intake of vitamin preparations for the prevention of AMD, the presence of a corrected refractive error, and previous ophthalmologist visits on the need for referral to an ophthalmologist was studied. Statistical significance was accepted based on two-sided values of <0.05.
2.5. Compliance
The study was conducted in compliance with the principles of the European Union Directive on Clinical Trials (2001/20/EC) and all local/regional requirements required to conform with the provisions of the Declaration of Helsinki (World Medical Association, Edinburgh, 2000). Approval was issued by the Ethics Committee of the University Hospitals Leuven before the study commenced.
3. Results
3.1. Patients’ Characteristics
The cohort included 102 people, who were all included for further analysis. Thus, 102 subjects and 203 eyes (one visitor was monophthalmic due to trauma) remained in the study group. Detailed baseline characteristics are listed in Table 1. The age ranged from 57 to 85 years (median 69.50 years) with 83% of the study population being aged ≥65 years. Overall, the subjects included were highly educated, with significantly more men reporting more than three years of higher education . All subjects that had been diagnosed with systemic pathology stated that this pathology was well controlled and under follow-up. In accordance with the inclusion criteria, the ocular status was deemed healthy by all 102 volunteers, with the absence of subjective visual impairment.
Characteristics, n = 102
Age (years), range (median)
57–85 (69.50)
Age (years in range), n (%)
<65
17 (17)
65–74
64 (63)
75–84
20 (19)
≥85
1 (1)
Male sex, n (%)
47 (46)
Education, n (%)
High school
12 (12)
≤3 years of higher education
66 (65)
>3 years of higher education
24 (23)
Smoking status, n (%), pack years, range (median)
Current smoker
3 (3)–4.4–50.0 (28.0)
Former smoker
47 (46)–0.1–39.0 (8.5)
Never smoked
52 (51)
Diabetes, n (%)
8 (8)
Arterial hypertension, n (%)
39 (38)
Neurological disorder, n (%)
16 (16)
Autoimmune disorder, n (%)
14 (14)
Family history of glaucoma, n (%)
17 (17)
Family history of AMD, n (%)
6 (6)
Intake of vitamin preparations for the prevention of AMD, n (%)
3 (3)
Pseudophakia/aphakia in at least one eye, n (%)
9 (9)
Correcting spectacles, n (%)
Distant sight
67 (66)
Reading
90 (88)
Time since last eye doctor visit, n (%)
<1 year
34 (33)
1–4 years
48 (47)
>4 years
13 (13)
Never
7 (7)
AMD = age-related macular degeneration.